VANQUA BIO
Live / Registered — Registered (as of 19 Nov 2024)
What this means for you
Registered since 19 Nov 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97840331
- Registration number
- 7573615
- Mark type
- Stylized text
- Filed
- 15 Mar 2023
- Published for opposition
- 23 Jan 2024
- Registered
- 19 Nov 2024
- Attorney of record
- Connie L. Ellerbach
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of neurodegenerative diseases, lysosomal disorders and disorders associated with dysregulated immune function
Owner
- Vanqua Bio, Inc., Chicago, IL, US
- Vanqua Bio, Inc., Chicago, IL, US
- Vanqua Bio, Inc., Chicago, IL, US
Prosecution history
- 19 Nov 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 19 Nov 2024 — REGISTERED-PRINCIPAL REGISTER
- 16 Oct 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 16 Oct 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 15 Oct 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 12 Aug 2024 — USE AMENDMENT FILED
- 15 Oct 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 12 Aug 2024 — TEAS STATEMENT OF USE RECEIVED
- 19 Mar 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 23 Jan 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 23 Jan 2024 — PUBLISHED FOR OPPOSITION
- 03 Jan 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 14 Dec 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 14 Dec 2023 — EXAMINER'S AMENDMENT ENTERED
- 14 Dec 2023 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED